ROSEVILLE, Minn., May 17, 2022 /PRNewswire/ — Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that management will participate in the following upcoming investor conferences:
H.C. Wainwright Global Investment Conference
Date: May 25, 2022
Time: 11:30 am ET
LD Micro Invitational (XII)
Date: June 8, 2022
Time: 7:30 am ET
To schedule a meeting with management, please reach out to firstname.lastname@example.org.
The presentations will be available for viewing and replay from the Investors section of Calyxt’s website at www.calyxt.com.
Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers’ materials and products. As plant-based solutions, the Company’s synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt’s diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.
PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.
|Calyxt Media Contact:||Calyxt Investor Relations Contact:|
|David Rosen/ John Garabo/ Michael Barron Argot Partners (212) 600-1902 email@example.com||Kimberly Minarovich/ Cameron Willis |
Argot Partners (212) 600-1902 firstname.lastname@example.org
|Calyxt Business Development Contact:|
|Gerry Nuovo Senior Vice President of Business Development (612) 427-7881 email@example.com|
SOURCE Calyxt, Inc.